This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Oliver Wessely: Innovator in Hematopoietic Progenitor Cell Cultivation
Introduction
Oliver Wessely is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of cell biology, particularly in the preparation and cultivation of hematopoietic progenitor cells. His work is essential for advancements in regenerative medicine and therapeutic applications.
Latest Patents
Wessely holds a patent for a "Process for preparing and cultivating hematopoietic progenitor cells." This innovation is crucial for improving the efficiency and effectiveness of cell therapies.
Career Highlights
Oliver Wessely is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development in the field of cell therapy, where he applies his expertise to advance medical science.
Collaborations
Wessely has collaborated with esteemed colleagues such as Hartmut Beug and Peter Steinlein. These partnerships have fostered a productive research environment, leading to significant advancements in their shared field of study.
Conclusion
Oliver Wessely's contributions to the field of hematopoietic progenitor cell cultivation highlight his role as an innovator in medical research. His work continues to impact the future of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile